CTOs on the Move

Surmodics

www.surmodics.com

 
Surmodics partners with the world`s leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. Throughout its transformation, Surmodics` mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.surmodics.com
  • 9924 West 74th Street
    Eden Prairie, MN USA 55344
  • Phone: 952.500.7000

Executives

Name Title Contact Details
Bryan Phillips
 Senior Vice President of Legal, Human Resources and Information Technology, General Counsel and Secretary Profile

Similar Companies

Curbell Electronics

Curbell Electronics is a Orchard Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroAire

MicroAire is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parker Medical Inc

Parker Medical Inc is a Bridgewater, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tri-State Surgical Supply and Equipment

Tri-State Surgical Supply and Equipment is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Benvenue Medical

Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by InterWest Partners, Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.